Buy NovaBay Pharmaceuticals Stock | NBY Stock Price & Latest News | Public
NBY

NovaBay Pharmaceuticals

$0.00 (0.00%)Today
    Small Market Cap
    View NovaBay Pharmaceuticals (NBY) stock trends here

    About NBY

    NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in developing products for the eye care market. Its products include Avenova, NeutroPhase, and CelleRx. The company was founded by Ramin Najafi on January 19, 2000 and is headquartered in Emeryv...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.05
    -0.1
    -0.15
    Q2 2020
    Q3 2020
    Q4 2020
    Q1 2021

    Expected EPS
    Q1 2021

    -$0.05

    Actual EPS
    Q1 2021

    Stats

    Market Cap$38,15M
    Volume137,65k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$1.94
    1 Year Low$0.24
    Open$0.94
    High$0.95
    Low$0.87

    Buy any stock with any amount of money.

    Download the App
    Download the app